 | • レポートコード：QFJ1-4375 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、革新的医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物医療、化学医療）、用途別市場規模（病院・クリニック、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・革新的医薬品の市場動向 ・企業の競争状況、市場シェア ・革新的医薬品の種類別市場規模と予測2016-2027（生物医療、化学医療） ・革新的医薬品の用途別市場規模と予測2016-2027（病院・クリニック、薬局、その他） ・革新的医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・革新的医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・革新的医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・革新的医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・革新的医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim） ・結論 |
Innovative drugs refer to drugs with proprietary intellectual property rights.
Market Analysis and Insights: Global Innovative Drug Market
The global Innovative Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Innovative Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Innovative Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Innovative Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Innovative Drug market.
Global Innovative Drug Scope and Market Size
Innovative Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Innovative Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Biological Medicine
Chemical Medicine
Segment by Application
Hospitals and Clinics
Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Innovative Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biological Medicine
1.2.3 Chemical Medicine
1.3 Market by Application
1.3.1 Global Innovative Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Innovative Drug Market Perspective (2016-2027)
2.2 Innovative Drug Growth Trends by Regions
2.2.1 Innovative Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Innovative Drug Historic Market Share by Regions (2016-2021)
2.2.3 Innovative Drug Forecasted Market Size by Regions (2022-2027)
2.3 Innovative Drug Industry Dynamic
2.3.1 Innovative Drug Market Trends
2.3.2 Innovative Drug Market Drivers
2.3.3 Innovative Drug Market Challenges
2.3.4 Innovative Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Innovative Drug Players by Revenue
3.1.1 Global Top Innovative Drug Players by Revenue (2016-2021)
3.1.2 Global Innovative Drug Revenue Market Share by Players (2016-2021)
3.2 Global Innovative Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Innovative Drug Revenue
3.4 Global Innovative Drug Market Concentration Ratio
3.4.1 Global Innovative Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Innovative Drug Revenue in 2020
3.5 Innovative Drug Key Players Head office and Area Served
3.6 Key Players Innovative Drug Product Solution and Service
3.7 Date of Enter into Innovative Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Innovative Drug Breakdown Data by Type
4.1 Global Innovative Drug Historic Market Size by Type (2016-2021)
4.2 Global Innovative Drug Forecasted Market Size by Type (2022-2027)
5 Innovative Drug Breakdown Data by Application
5.1 Global Innovative Drug Historic Market Size by Application (2016-2021)
5.2 Global Innovative Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Innovative Drug Market Size (2016-2027)
6.2 North America Innovative Drug Market Size by Type
6.2.1 North America Innovative Drug Market Size by Type (2016-2021)
6.2.2 North America Innovative Drug Market Size by Type (2022-2027)
6.2.3 North America Innovative Drug Market Size by Type (2016-2027)
6.3 North America Innovative Drug Market Size by Application
6.3.1 North America Innovative Drug Market Size by Application (2016-2021)
6.3.2 North America Innovative Drug Market Size by Application (2022-2027)
6.3.3 North America Innovative Drug Market Size by Application (2016-2027)
6.4 North America Innovative Drug Market Size by Country
6.4.1 North America Innovative Drug Market Size by Country (2016-2021)
6.4.2 North America Innovative Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Innovative Drug Market Size (2016-2027)
7.2 Europe Innovative Drug Market Size by Type
7.2.1 Europe Innovative Drug Market Size by Type (2016-2021)
7.2.2 Europe Innovative Drug Market Size by Type (2022-2027)
7.2.3 Europe Innovative Drug Market Size by Type (2016-2027)
7.3 Europe Innovative Drug Market Size by Application
7.3.1 Europe Innovative Drug Market Size by Application (2016-2021)
7.3.2 Europe Innovative Drug Market Size by Application (2022-2027)
7.3.3 Europe Innovative Drug Market Size by Application (2016-2027)
7.4 Europe Innovative Drug Market Size by Country
7.4.1 Europe Innovative Drug Market Size by Country (2016-2021)
7.4.2 Europe Innovative Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Innovative Drug Market Size (2016-2027)
8.2 Asia-Pacific Innovative Drug Market Size by Type
8.2.1 Asia-Pacific Innovative Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Innovative Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Innovative Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Innovative Drug Market Size by Application
8.3.1 Asia-Pacific Innovative Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Innovative Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Innovative Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Innovative Drug Market Size by Region
8.4.1 Asia-Pacific Innovative Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Innovative Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Innovative Drug Market Size (2016-2027)
9.2 Latin America Innovative Drug Market Size by Type
9.2.1 Latin America Innovative Drug Market Size by Type (2016-2021)
9.2.2 Latin America Innovative Drug Market Size by Type (2022-2027)
9.2.3 Latin America Innovative Drug Market Size by Type (2016-2027)
9.3 Latin America Innovative Drug Market Size by Application
9.3.1 Latin America Innovative Drug Market Size by Application (2016-2021)
9.3.2 Latin America Innovative Drug Market Size by Application (2022-2027)
9.3.3 Latin America Innovative Drug Market Size by Application (2016-2027)
9.4 Latin America Innovative Drug Market Size by Country
9.4.1 Latin America Innovative Drug Market Size by Country (2016-2021)
9.4.2 Latin America Innovative Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Innovative Drug Market Size (2016-2027)
10.2 Middle East & Africa Innovative Drug Market Size by Type
10.2.1 Middle East & Africa Innovative Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Innovative Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Innovative Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Innovative Drug Market Size by Application
10.3.1 Middle East & Africa Innovative Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Innovative Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Innovative Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Innovative Drug Market Size by Country
10.4.1 Middle East & Africa Innovative Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Innovative Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Innovative Drug Introduction
11.1.4 Pfizer Revenue in Innovative Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Innovative Drug Introduction
11.2.4 Roche Revenue in Innovative Drug Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Innovative Drug Introduction
11.3.4 Sanofi Revenue in Innovative Drug Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Innovative Drug Introduction
11.4.4 Johnson & Johnson Revenue in Innovative Drug Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Details
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Innovative Drug Introduction
11.5.4 Merck & Co. (MSD) Revenue in Innovative Drug Business (2016-2021)
11.5.5 Merck & Co. (MSD) Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Innovative Drug Introduction
11.6.4 Novartis Revenue in Innovative Drug Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Innovative Drug Introduction
11.7.4 AbbVie Revenue in Innovative Drug Business (2016-2021)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Innovative Drug Introduction
11.8.4 Gilead Sciences Revenue in Innovative Drug Business (2016-2021)
11.8.5 Gilead Sciences Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Details
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Innovative Drug Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Innovative Drug Business (2016-2021)
11.9.5 GlaxoSmithKline (GSK) Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Innovative Drug Introduction
11.10.4 Amgen Revenue in Innovative Drug Business (2016-2021)
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Innovative Drug Introduction
11.11.4 AstraZeneca Revenue in Innovative Drug Business (2016-2021)
11.11.5 AstraZeneca Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Innovative Drug Introduction
11.12.4 Bristol-Myers Squibb Revenue in Innovative Drug Business (2016-2021)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Innovative Drug Introduction
11.13.4 Eli Lilly Revenue in Innovative Drug Business (2016-2021)
11.13.5 Eli Lilly Recent Development
11.14 Teva
11.14.1 Teva Company Details
11.14.2 Teva Business Overview
11.14.3 Teva Innovative Drug Introduction
11.14.4 Teva Revenue in Innovative Drug Business (2016-2021)
11.14.5 Teva Recent Development
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Innovative Drug Introduction
11.15.4 Bayer Revenue in Innovative Drug Business (2016-2021)
11.15.5 Bayer Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Details
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Innovative Drug Introduction
11.16.4 Novo Nordisk Revenue in Innovative Drug Business (2016-2021)
11.16.5 Novo Nordisk Recent Development
11.17 Allergan
11.17.1 Allergan Company Details
11.17.2 Allergan Business Overview
11.17.3 Allergan Innovative Drug Introduction
11.17.4 Allergan Revenue in Innovative Drug Business (2016-2021)
11.17.5 Allergan Recent Development
11.18 Takeda
11.18.1 Takeda Company Details
11.18.2 Takeda Business Overview
11.18.3 Takeda Innovative Drug Introduction
11.18.4 Takeda Revenue in Innovative Drug Business (2016-2021)
11.18.5 Takeda Recent Development
11.18 Boehringer Ingelheim
.1 Boehringer Ingelheim Company Details
.2 Boehringer Ingelheim Business Overview
.3 Boehringer Ingelheim Innovative Drug Introduction
.4 Boehringer Ingelheim Revenue in Innovative Drug Business (2016-2021)
.5 Boehringer Ingelheim Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Innovative Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biological Medicine
Table 3. Key Players of Chemical Medicine
Table 4. Global Innovative Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Innovative Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Innovative Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Innovative Drug Market Share by Regions (2016-2021)
Table 8. Global Innovative Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Innovative Drug Market Share by Regions (2022-2027)
Table 10. Innovative Drug Market Trends
Table 11. Innovative Drug Market Drivers
Table 12. Innovative Drug Market Challenges
Table 13. Innovative Drug Market Restraints
Table 14. Global Innovative Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Innovative Drug Market Share by Players (2016-2021)
Table 16. Global Top Innovative Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Innovative Drug as of 2020)
Table 17. Ranking of Global Top Innovative Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Innovative Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Innovative Drug Product Solution and Service
Table 21. Date of Enter into Innovative Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Innovative Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Innovative Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Innovative Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Innovative Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Innovative Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Innovative Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Innovative Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Innovative Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Innovative Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Innovative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Innovative Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Innovative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Innovative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Innovative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Innovative Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Innovative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Innovative Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Innovative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Innovative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Innovative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Innovative Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Innovative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Innovative Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Innovative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Innovative Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Innovative Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Innovative Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Innovative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Innovative Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Innovative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Innovative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Innovative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Innovative Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Innovative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Innovative Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Innovative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Innovative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Innovative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Innovative Drug Product
Table 64. Pfizer Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Innovative Drug Product
Table 69. Roche Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Innovative Drug Product
Table 74. Sanofi Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Innovative Drug Product
Table 79. Johnson & Johnson Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Merck & Co. (MSD) Company Details
Table 82. Merck & Co. (MSD) Business Overview
Table 83. Merck & Co. (MSD) Innovative Drug Product
Table 84. Merck & Co. (MSD) Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 85. Merck & Co. (MSD) Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Innovative Drug Product
Table 89. Novartis Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. AbbVie Company Details
Table 92. AbbVie Business Overview
Table 93. AbbVie Innovative Drug Product
Table 94. AbbVie Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 95. AbbVie Recent Development
Table 96. Gilead Sciences Company Details
Table 97. Gilead Sciences Business Overview
Table 98. Gilead Sciences Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 99. Gilead Sciences Recent Development
Table 100. GlaxoSmithKline (GSK) Company Details
Table 101. GlaxoSmithKline (GSK) Business Overview
Table 102. GlaxoSmithKline (GSK) Innovative Drug Product
Table 103. GlaxoSmithKline (GSK) Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 104. GlaxoSmithKline (GSK) Recent Development
Table 105. Amgen Company Details
Table 106. Amgen Business Overview
Table 107. Amgen Innovative Drug Product
Table 108. Amgen Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 109. Amgen Recent Development
Table 110. AstraZeneca Company Details
Table 111. AstraZeneca Business Overview
Table 112. AstraZeneca Innovative Drug Product
Table 113. AstraZeneca Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 114. AstraZeneca Recent Development
Table 115. Bristol-Myers Squibb Company Details
Table 116. Bristol-Myers Squibb Business Overview
Table 117. Bristol-Myers Squibb Innovative Drug Product
Table 118. Bristol-Myers Squibb Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Eli Lilly Company Details
Table 121. Eli Lilly Business Overview
Table 122. Eli Lilly Innovative Drug Product
Table 123. Eli Lilly Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 124. Eli Lilly Recent Development
Table 125. Teva Company Details
Table 126. Teva Business Overview
Table 127. Teva Innovative Drug Product
Table 128. Teva Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 129. Teva Recent Development
Table 130. Bayer Company Details
Table 131. Bayer Business Overview
Table 132. Bayer Innovative Drug Product
Table 133. Bayer Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 134. Bayer Recent Development
Table 135. Novo Nordisk Company Details
Table 136. Novo Nordisk Business Overview
Table 137. Novo Nordisk Innovative Drug Product
Table 138. Novo Nordisk Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 139. Novo Nordisk Recent Development
Table 140. Allergan Company Details
Table 141. Allergan Business Overview
Table 142. Allergan Innovative Drug Product
Table 143. Allergan Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 144. Allergan Recent Development
Table 145. Takeda Company Details
Table 146. Takeda Business Overview
Table 147. Takeda Innovative Drug Product
Table 148. Takeda Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 149. Takeda Recent Development
Table 150. Boehringer Ingelheim Company Details
Table 151. Boehringer Ingelheim Business Overview
Table 152. Boehringer Ingelheim Innovative Drug Product
Table 153. Boehringer Ingelheim Revenue in Innovative Drug Business (2016-2021) & (US$ Million)
Table 154. Boehringer Ingelheim Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Innovative Drug Market Share by Type: 2020 VS 2027
Figure 2. Biological Medicine Features
Figure 3. Chemical Medicine Features
Figure 4. Global Innovative Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Others Case Studies
Figure 8. Innovative Drug Report Years Considered
Figure 9. Global Innovative Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Innovative Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Innovative Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Innovative Drug Market Share by Regions (2022-2027)
Figure 13. Global Innovative Drug Market Share by Players in 2020
Figure 14. Global Top Innovative Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Innovative Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Innovative Drug Revenue in 2020
Figure 16. Global Innovative Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Innovative Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Innovative Drug Market Share by Type (2016-2027)
Figure 20. North America Innovative Drug Market Share by Application (2016-2027)
Figure 21. North America Innovative Drug Market Share by Country (2016-2027)
Figure 22. United States Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Innovative Drug Market Share by Type (2016-2027)
Figure 26. Europe Innovative Drug Market Share by Application (2016-2027)
Figure 27. Europe Innovative Drug Market Share by Country (2016-2027)
Figure 28. Germany Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Innovative Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Innovative Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Innovative Drug Market Share by Region (2016-2027)
Figure 38. China Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Innovative Drug Market Share by Type (2016-2027)
Figure 46. Latin America Innovative Drug Market Share by Application (2016-2027)
Figure 47. Latin America Innovative Drug Market Share by Country (2016-2027)
Figure 48. Mexico Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Innovative Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Innovative Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Innovative Drug Market Share by Country (2016-2027)
Figure 54. Turkey Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Innovative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 58. Roche Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 61. Merck & Co. (MSD) Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 64. Gilead Sciences Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 65. GlaxoSmithKline (GSK) Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 70. Teva Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 71. Bayer Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 72. Novo Nordisk Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 73. Allergan Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 74. Takeda Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 75. Boehringer Ingelheim Revenue Growth Rate in Innovative Drug Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…- 世界の抗コリン薬市場規模・現状・予測（2021年-2027年） Anticholinergic drugs are used to restrict the acetylcholine-provoked neurotransmission in different parts of the body including heart, peripheral nervous system, and other parts. Acetylcholine controls the involuntary functions such as salivation, sweating, digestion, and several others. The drug i…
- 世界のがん生物毒素治療薬市場規模・現状・予測（2021年-2027年） Treatment of cancer disease depends on the stage of disease progression. Chemotherapy is widely used in earlier stages but there are other therapy options like immunological therapy and targeted drugs used in later stages. Market Analysis and Insights: Global Cancer Biological Toxins Drug Market The…
- 世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
- 世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年） Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria. Market Analysis and Insights: Global Acute Hepatic Porphyria Drug Market The global Acute Hepatic Porphyria Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…